6230 articles
Maze Therapeutics' MZE829 reduced kidney damage markers by over 35% in patients with APOL1-mediated kidney disease in Phase 2 trials.
Sotatercept reduced dangerous pressure in heart failure patients' lungs and improved walking ability in phase 2 study.
New review reveals how saturated fat-rich diets trigger neuroinflammation and cognitive decline, but offers actionable prevention strategies.
New research reveals how targeting cryptochromes, key circadian clock proteins, may offer breakthrough treatments for diabetes, cancer, and sleep disorders.
Large study reveals U-shaped relationship between maternal uric acid and pregnancy risks, suggesting optimal levels exist.
New research reveals how skin microbes trigger severe immune reactions to cancer treatments, offering hope for prevention strategies.
Combining ixekizumab with tirzepatide achieved better joint health and significant weight loss compared to arthritis treatment alone.
New research reveals how elevated Lp(a) levels interact with hormonal changes to significantly increase venous thromboembolism risk.
New research shows combining weight-loss medications with hormone therapy could transform health outcomes for obese men with low testosterone.
New research reveals how disrupted circadian genes cause insomnia via neurotransmitter imbalance, inflammation, and metabolic dysfunction.
Research on Candida albicans uncovers how protein interactions regulate toxic compound removal and cellular health balance.
New review examines how vegetarian, vegan, Mediterranean, and EAT-Lancet diets impact both environmental sustainability and chronic disease risk.
